NYSE Arca · INFU
InfuSystems Holdings, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for INFU: Nov 03, 2026
InfuSystems Holdings, Inc. Common Stock is expected to report earnings on 11/03/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. The reported EPS for the same quarter last year was $0.11.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · The Motley Fool · Zacks- RTTNews · Oct 6, 3:37 AM EDTBiotech Stocks At 52-Week Highs – PCVX +31% On Phase 3 Results, INFU, ILMN +7%, CRL+7%, HTFL +5%(RTTNews) – The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.
- RTTNews · Sep 23, 8:25 AM EDTBiotech Stocks At 52-Week Highs – OMER +13%, TKNO +5%, BLFS, SDGR, INFU(RTTNews) – The following biotech stocks reached a 52-week high on September 22, 2026, driven by key catalysts such as positive quarterly reports or results from clinical trials.
- The Motley Fool · Aug 11, 1:31 PM EDTInfuSystem (INFU) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · Aug 5, 4:09 AM EDTBiotech Stocks At 52-Week Highs – UFPT +25%, INFU +33%, SOPH +20% On Q2 Reports, REPL, PBLS(RTTNews) – The following biotech stocks reached a 52-week high on August 4, 2026, driven by key catalysts like positive quarterly results or certain regulatory milestones.
- Zacks · Aug 4, 7:50 AM EDTInfuSystems Holdings, Inc. (INFU) Q2 Earnings and Revenues Surpass EstimatesInfuSystems Holdings (INFU) delivered earnings and revenue surprises of +25.00% and +1.19%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Aug 4, 6:44 AM EDTInfuSystem Holdings, Inc Q2 Income Climbs(RTTNews) – InfuSystem Holdings, Inc (INFU) released a profit for its second quarter that Increased, from the same period last year
- Zacks · Jun 29, 9:40 AM EDTAre Investors Undervaluing InfuSystems Holdings (INFU) Right Now?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- Zacks · Jun 29, 5:42 AM EDTInfuSystems Holdings (INFU) Soars 11.1%: Is Further Upside Left in the Stock?InfuSystems Holdings (INFU) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- Zacks · Jun 12, 9:40 AM EDTShould Value Investors Buy InfuSystems Holdings (INFU) Stock?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- Zacks · Jun 5, 9:55 AM EDTDoes InfuSystems Holdings (INFU) Have the Potential to Rally 62.61% as Wall Street Analysts Expect?The consensus price target hints at a 62.6% upside potential for InfuSystems Holdings (INFU). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- Zacks · Jun 4, 12:45 PM EDTHere is Why Growth Investors Should Buy InfuSystems Holdings (INFU) NowInfuSystems Holdings (INFU) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- Zacks · May 21, 12:00 PM EDTWhat Makes InfuSystems Holdings (INFU) a New Buy StockInfuSystems Holdings (INFU) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for InfuSystems Holdings, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.